Reports on Indiana VC activity differ starkly
Last year, one research firm pegged Indiana’s 2015 venture capital activity at about $55 million. This year, another firm said it was about $157 million.
Investing
Articles
FOCUS: Will Trump’s policies push markets higher?
Six experts talk about what the new administration, rising Fed rates, oil prices, Brexit and more mean for 2017.
SKARBECK: A memo about investing to my daughters and nieces
In prior generations, women were often in the dark on money matters. Taking an active role from the start to oversee your financial future will benefit you over the long term.
Ed-tech startup raises $1.25M from investors, including Simon family members
This is the second capital raise for ClearScholar, which runs an app for college students that aims to be a primary digital destination for school information.
Two men charged with securities fraud for alleged Ponzi scheme
George R. McKown, 65, of Indianapolis and another man are accused of taking part in a Ponzi-like scheme that robbed numerous investors of their retirement savings.
Sears Holdings lines up $200M in financing to stay afloat
The move signals that hedge fund manager Eddie Lampert remains committed to bankrolling Sears, even as the once-mighty department-store chain suffers from dwindling sales and billions in red ink.
SKARBECK: State has come long way since its founding in 1816
One can argue that 200 years is the blink of an eye in the transcript of history. It’s remarkable to observe the progress that has transpired in Indiana since statehood was achieved in 1816.
Securities watchdog bans second broker in alleged Veros Ponzi scheme
FINRA permanently banned a former stockbroker from practicing in the securities industry after he refused to testify about an ongoing civil Ponzi scheme suit.
Feds bring charges in alleged fraud scheme that stung CNO Financial
Prosecutors accused Platinum Partners of carrying out a $1 billion fraud that included setting up an affiliate to bamboozle institutional investors—including CNO Financial Group—into investing in the teetering hedge fund.
Fed raises rate, boosts outlook for borrowing costs in 2017
New projections show the central bankers expect three separate quarter-point rate increases in 2017, up from the two seen in the previous forecasts.
Federal Reserve expected to raise rates for first time in a year
The Fed last increased rates in December a year ago, when it hiked its benchmark rate from a record low set at the depths of the 2008 financial crisis.
Supreme Court upholds broad power to curb insider trading
The justices ruled Tuesday that sharing corporate secrets with friends or relatives is illegal even if the insider providing the tip doesn't receive anything of value in return.
Fair Finance CFO seeks reduction of sentence
Rick D. Snow—who was convicted in 2012 of helping Tim Durham and Jim Cochran loot Fair Finance Co. but didn’t raid the company’s coffers himself—is seeking to get his 10-year sentence reduced.
Buy, sell or hold after Lilly’s Alzheimer’s flop?
Analysts are all over the map on how investors should react to the Indianapolis-based drugmaker’s news that a promising drug failed to help patients.
SKARBECK: Opportunistic investors can profit on deal spreads
Recently, the potential returns on several arbitrage deals have widened, namely because regulators have increased their scrutiny of mergers for antitrust reasons.
Dow breaks 19,000 mark as stock indexes reach record territory
The Dow Jones Industrial Average on Tuesday morning climbed above 19,000 for the first time, as U.S. stocks added to gains that pushed four major equity benchmarks to simultaneous records for the first time since 1999.
Firms’ infatuation with buybacks creating economic drag
Investment strategist Jeff Korzenik said executives often have an incentive to buy back stock rather than using that cash to make capital expenditures.
Drugmakers’ stocks jump on promise of Trump presidency
Pharmaceutical company stocks were among the winners in early trading Wednesday as Republicans’ sweeping election victory eased concerns that Democrats would enact controls on drug prices. Eli Lilly and Co. shares jumped 4 percent.
Fed widely expected to leave key interest rate unchanged
With voters set to choose a new president and Congress in six days, the Federal Reserve will likely keep a low profile when it ends a meeting Wednesday to try to ensure it doesn't become part of the debate at the close of a tumultuous political campaign.
Angie’s List hires investment bankers, setting stage for possible sale
The home services marketplace did not specify it planned to sell itself, but hiring investment bankers is typically the first step in doing so. In a press release, CEO Scott Durchslag said only that the goal was “to achieve the full potential of our new platform.”